Alembic Pharmaceuticals is reportedly planning for major expansion to feed its international markets in the areas of dermatology, oncology solids and injectibles, ophthalmics and general injectibles. In this regards, the company has laid down investment plans of Rs 600 crore for the fiscal 2017-18, out of which it has invested Rs 300 crore for setting up greenfield projects.
Moreover, the company is investing to create new capabilities that will cater to its international market. It is entering into the injectibles space, dermatology and oncology for the international markets.
Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907.
